Janus Henderson Group PLC Lowers Holdings in The Beauty Health Company (NASDAQ:SKIN)

Janus Henderson Group PLC decreased its position in The Beauty Health Company (NASDAQ:SKIN) by 0.1% in the first quarter, Holdings Channel reports. The firm owned 11,286,468 shares of the company’s stock after selling 13,459 shares during the period. Janus Henderson Group PLC owned 0.09% of Beauty Health worth $50,112,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the company. Raymond James & Associates purchased a new stake in Beauty Health during the fourth quarter worth $31,000. Raymond James Financial Services Advisors Inc. purchased a new stake in Beauty Health during the fourth quarter worth $31,000. HighMark Wealth Management LLC purchased a new stake in Beauty Health during the first quarter worth $31,000. SageView Advisory Group LLC purchased a new stake in Beauty Health during the first quarter worth $60,000. Finally, Aigen Investment Management LP lifted its holdings in Beauty Health by 88.7% during the fourth quarter. Aigen Investment Management LP now owns 31,865 shares of the company’s stock worth $99,000 after buying an additional 14,974 shares during the period. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Piper Sandler lowered their target price on Beauty Health from $2.50 to $1.50 and set an “underweight” rating for the company in a report on Thursday, July 11th. TD Cowen lowered their target price on Beauty Health from $4.00 to $3.00 and set a “hold” rating for the company in a report on Monday, May 13th. DA Davidson restated a “buy” rating and set a $5.00 target price on shares of Beauty Health in a report on Monday, May 13th. Finally, Stifel Nicolaus reduced their price target on Beauty Health from $4.00 to $2.00 and set a “hold” rating on the stock in a research report on Friday. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Beauty Health currently has a consensus rating of “Hold” and a consensus target price of $5.86.

Beauty Health Price Performance

Beauty Health stock traded down $0.07 during midday trading on Tuesday, reaching $1.80. The company had a trading volume of 766,876 shares, compared to its average volume of 2,132,679. The company has a market capitalization of $222.53 million, a P/E ratio of -2.67 and a beta of 0.96. The Beauty Health Company has a 12-month low of $1.35 and a 12-month high of $8.36. The firm’s fifty day simple moving average is $2.02 and its 200-day simple moving average is $2.87. The company has a debt-to-equity ratio of 10.51, a current ratio of 6.57 and a quick ratio of 5.55.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.14) by $0.04. The business had revenue of $81.40 million during the quarter, compared to the consensus estimate of $80.56 million. Beauty Health had a negative net margin of 20.48% and a negative return on equity of 0.02%. The business’s revenue was down 5.7% compared to the same quarter last year. During the same quarter last year, the firm earned ($0.17) EPS. As a group, equities analysts anticipate that The Beauty Health Company will post -0.07 EPS for the current year.

Beauty Health Company Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.